As of August 28, 2026, Keros Therapeutics, Inc. (KROS) has a DilutionWatch DilutionScore of 22/100, rated LOW dilution risk. Keros Therapeutics, Inc. has a market capitalization of $222.66M, 19.83M shares outstanding, 152 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
💰Cash Runway—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for KROS.
Market Data
Market Cap$222.66M
Shares Outstanding19.83M
Float17.83M
Cash$257.61M
Debt$16.31M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 2.8% shares (2026Q1 vs prior)
152 institutional holders · 21.90M shares
#1
BlackRock, Inc.
2.41M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
1.66M shares
#3
Nantahala Capital Management, LLC
1.36M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest985.6K
Days to Cover5.9
% of Float5.5%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2020-12-31
4
INSIDER TRANSACTION
2026-03-11
4
INSIDER TRANSACTION
2026-03-11
3
FORM3
2026-03-11
4
INSIDER TRANSACTION
2026-02-26
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual KROS Dilution Snapshot
Keros Therapeutics, Inc. (KROS) has a DilutionScore of 22/100, rated Low dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for KROS: 4 on 2026-03-11; 4 on 2026-03-11; 3 on 2026-03-11.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track KROS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KROS — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for KROS
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.